Cargando…

Comparison of SARS-CoV-2 serological assays for use in epidemiological surveillance in Scotland

BACKGROUND: Sero-surveillance of SARS-CoV-2 is crucial to monitoring levels of population exposure and informing public health responses, but may be influenced by variability in performance between available assays. METHODS: Five commercial immunoassays and a neutralising activity assay were used to...

Descripción completa

Detalles Bibliográficos
Autores principales:	McDonald, Lindsay, Wise, Helen, Muecksch, Frauke, Poston, Daniel, Mavin, Sally, Templeton, Kate, Furrie, Elizabeth, Richardson, Claire, McGuire, Jaqueline, Jarvis, Lisa, Malloy, Kristen, McAuley, Andrew, Palmateer, Norah, Dickson, Elizabeth, Hatziioannou, Theodora, Bieniasz, Paul, Jenks, Sara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Ltd. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200328/ https://www.ncbi.nlm.nih.gov/pubmed/35262014 http://dx.doi.org/10.1016/j.jcvp.2021.100028

Ejemplares similares

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: implications for the ability of serological assays to predict immunity
por: Muecksch, Frauke, et al.
Publicado: (2021)

Longitudinal variation in SARS-CoV-2 antibody levels and emergence of viral variants: a serological analysis
por: Muecksch, Frauke, et al.
Publicado: (2022)

Longitudinal analysis of clinical serology assay performance and neutralising antibody levels in COVID19 convalescents
por: Muecksch, Frauke, et al.
Publicado: (2020)

Longitudinal Serological Analysis and Neutralizing Antibody Levels in Coronavirus Disease 2019 Convalescent Patients
por: Muecksch, Frauke, et al.
Publicado: (2020)

Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting
por: McCance, Kirsty, et al.
Publicado: (2022)

Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection
por: Poston, Daniel, et al.
Publicado: (2020)

Absence of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Activity in Prepandemic Sera From Individuals With Recent Seasonal Coronavirus Infection
por: Poston, Daniel, et al.
Publicado: (2020)

National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic
por: Palmateer, N.E., et al.
Publicado: (2021)

National population prevalence of antibodies to SARS-CoV-2 among pregnant women in Scotland during the second wave of the COVID-19 pandemic: a prospective national serosurvey
por: McAuley, A., et al.
Publicado: (2021)

Enhanced surveillance of COVID-19 in Scotland: population-based seroprevalence surveillance for SARS-CoV-2 during the first wave of the epidemic
por: Dickson, E., et al.
Publicado: (2021)

Antigen presentation dynamics shape the response to emergent variants like SARS-CoV-2 Omicron strain after multiple vaccinations with wild type strain
por: Yang, Leerang, et al.
Publicado: (2022)

Antigen presentation dynamics shape the antibody response to variants like SARS-CoV-2 Omicron after multiple vaccinations with the original strain
por: Yang, Leerang, et al.
Publicado: (2023)

SARS-CoV-2 spike glycosylation affects function and neutralization sensitivity
por: Zhang, Fengwen, et al.
Publicado: (2023)

High willingness to use drug consumption rooms among people who inject drugs in Scotland: findings from a national bio-behavioural survey among people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2021)

Examining the impact of the first wave of COVID-19 and associated control measures on interventions to prevent blood-borne viruses among people who inject drugs in Scotland: an interrupted time series study
por: Trayner, Kirsten M.A., et al.
Publicado: (2022)

A Recombinant Protein SARS-CoV-2 Candidate Vaccine Elicits High-titer Neutralizing Antibodies in Macaques.
por: Baisa, Gary, et al.
Publicado: (2021)

“A recombinant protein SARS-CoV-2 candidate vaccine elicits high-titer neutralizing antibodies in macaques.”
por: Baisa, Gary, et al.
Publicado: (2020)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Plasma neutralization properties of the SARS-CoV-2 Omicron variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Screening for delirium within intensive care units in scotland: a national survey
por: McGuire, AW, et al.
Publicado: (2015)

‘I’m not going to leave someone to die’: carriage of naloxone by police in Scotland within a public health framework: a qualitative study of acceptability and experiences
por: Speakman, Elizabeth M., et al.
Publicado: (2023)

Effectiveness of Scotland's National Naloxone Programme for reducing opioid‐related deaths: a before (2006–10) versus after (2011–13) comparison
por: Bird, Sheila M., et al.
Publicado: (2016)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2022)

Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization After Messenger RNA Vaccination and Variant Breakthrough Infection
por: Gaebler, Christian, et al.
Publicado: (2022)

SIV Nef Proteins Recruit the AP-2 Complex to Antagonize Tetherin and Facilitate Virion Release
por: Zhang, Fengwen, et al.
Publicado: (2011)

Mutational escape from the polyclonal antibody response to SARS-CoV-2 infection is largely shaped by a single class of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Mapping mutations to the SARS-CoV-2 RBD that escape binding by different classes of antibodies
por: Greaney, Allison J., et al.
Publicado: (2021)

Epistasis lowers the genetic barrier to SARS-CoV-2 neutralizing antibody escape
por: Witte, Leander, et al.
Publicado: (2023)

Increased risk of HIV and other drug-related harms associated with injecting in public places: national bio-behavioural survey of people who inject drugs
por: Trayner, Kirsten M.A., et al.
Publicado: (2020)

A pragmatic harm reduction approach to manage a large outbreak of wound botulism in people who inject drugs, Scotland 2015
por: Trayner, Kirsten M. A., et al.
Publicado: (2018)

Antibody potency, effector function and combinations in protection from SARS-CoV-2 infection in vivo
por: Schäfer, Alexandra, et al.
Publicado: (2020)

Vaccine Breakthrough Infections with SARS-CoV-2 Variants
por: Hacisuleyman, Ezgi, et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Broad cross-reactivity across sarbecoviruses exhibited by a subset of COVID-19 donor-derived neutralizing antibodies
por: Jette, Claudia A., et al.
Publicado: (2021)

Conference on Topological Methods in Algebraic Topology
por: McAuley, Louis
Publicado: (1974)

Assisted Evolution Enables HIV-1 to Overcome a High TRIM5α-Imposed Genetic Barrier to Rhesus Macaque Tropism
por: Soll, Steven J., et al.
Publicado: (2013)

Delirium in COVID-19: can we make the unknowns knowns?
por: Wilcox, M. Elizabeth, et al.
Publicado: (2021)

The Operator for the Teeth
por: McAuley, J. E.
Publicado: (1970)

Multimedia Networks: what's new?
por: McAuley, D R
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_uv65i0ccriusq415upr6pm9pna